Cost of treating peripheral neuropathic pain with pregabalin or gabapentin at therapeutic doses in routine practice.
CONCLUSION: At therapeutic doses, pregabalin was found to have lower healthcare and non-healthcare costs than gabapentin in routine practice.
PMID: 29754518 [PubMed - as supplied by publisher]
Source: Journal of Comparative Effectiveness Research - Category: General Medicine Tags: J Comp Eff Res Source Type: research
More News: Brain | Electronic Medical Records (EMR) | Gabapentin | General Medicine | Healthcare Costs | Lyrica | Neurology | Neurontin | Pain | Primary Care | Study